Pierre Sabatier
Researcher at Department of Surgical Sciences; Thoracic Surgery
- E-mail:
- pierre.sabatier@uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 50, 4 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 50, 4 tr
751 85 UPPSALA
Publications
Recent publications
-
GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
Part of Cell Chemical Biology, p. 1284-1299, 2026
- DOI for GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
- Download full text (pdf) of GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
-
Part of Cell Stem Cell, p. 1324-1338, 2026
- DOI for Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
- Download full text (pdf) of Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
-
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
Part of Cell, 2025
- DOI for GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
- Download full text (pdf) of GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
All publications
Articles in journal
-
GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
Part of Cell Chemical Biology, p. 1284-1299, 2026
- DOI for GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
- Download full text (pdf) of GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
-
Part of Cell Stem Cell, p. 1324-1338, 2026
- DOI for Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
- Download full text (pdf) of Extracellular vesicle secretome from mesenchymal stromal cells prevents post-ischemic heart failure by targeting cardiac fibrosis
-
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
Part of Cell, 2025
- DOI for GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
- Download full text (pdf) of GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity